NYC Dermatology & Laser Group In the News, Publications, Awards and Memberships

Links to our press can be found throughout our Instagram Mirror Page.

• Akhavan A, Rudikoff D. Atopic Dermatitis: Systemic Immunosuppressive Therapy. Semin Cutan Med Surg. 2008 Jun;27(2):151
• Akhavan A, Levitt J. Assessing Retinol Stability in a Hydroquinone 4%/Retinol 0.3% Cream in the Presence of Antioxidants and Sunscreen Under Simulated-Use Conditions: a Pilot Study. Clin Ther. 2008 Mar;30(3):543-7.
• Akhavan A, Alghaithi K, Rabach M, Mirchandani N, Cohen SR.Allergic Contact Stomatitis. Dermatitis. 2006 Jun;17(2):88-90.
• Akhavan A, Alghaithi K, Mirchandani N, Cohen SR.Mycobacterium Fortuitum Skin Infection Following a Pedicure and Footbath at a Nail Salon. In: Abstracts of the 64th Annual Meeting of the American Academy of Dermatology; San Francisco, CA; 2006.
• Akhavan A, Rudikoff D. Keratosis Pilaris and Variants.Treatments of Skin Disease, 2nd Edition. Edited by Lebwohl M et al. Mosby Ltd. 2005.
• Akhavan A, Wei H. Protective Effects of Baicalein Against the Initiation and Promotion of Carcinogenesis by Ultraviolet B Radiation in Mice. In: Abstracts of the 63rd Annual Meeting of the American Academy of Dermatology; New Orleans LA; 2005.
• Akhavan A, Bershad S. Topical Acne Drugs: Review of Clinical Properties and Safety. Am J Clin Dermatol. 2003;4(7):473-92.
• Akhavan A, Rudikoff D. The Treatment of Atopic Dermatitis with Systemic Immunosuppressive Agents. Clin Dermatol. 2003 May-Jun;21(3):225-40.
• Akhavan A, Cohen SR. The Relationship Between Atopic Dermatitis and Contact Dermatitis. Clin Dermatol. 2003 Mar-Apr;21(2):158-62.
• Rudikoff D, Akhavan A, Cohen SR. Color Atlas: Eczema. Clin Dermatol. 2003 Mar-Apr;21(2):101-8.
• Akhavan A, Wei H. Anti-Photocarcinogenesis of Baicalein. In: Abstract of the Mount Sinai School of Medicine Medical Student Research Day; New York, NY; February 2002.
• Buchsbaum MS, Nenadic I, Hazlett EA, Spiegel-Cohen J, Fleischman MB, Akhavan A, Silverman JM, Siever LJ. Differential Metabolic Rates in Prefrontal and Temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res. 2002 Mar 1;54(1-2):141-50.
• Akhavan A, Rudikoff D. Keratosis Pilaris and Variants.Treatments of Skin Disease,1st Edition. Edited by Lebwohl M et al. Mosby Ltd. 2001.
• Akhavan A, Hazlett E, Buchsbaum M. Metabolic Rate and Gray/White Composition of the Brodmann Areas of Frontal Lobe in Schizophrenia. In: Abstract of the Mount Sinai School of Medicine Medical Student Research Day; New York, NY; February 1999.
• Azfar RS, Schwartz RA, Berwick M: Primary Melanoma Prevention in Children. G Ital Dermatol Venereol 139: 267-272, 2004.
• Azfar RS, James WD.: Proliferative Verrucous Leukoplakia.Emedicine.com, Dermatology http://www.emedicine.com/derm/topic961.htmApril 2008 Notes: Updated December, 2009.
• Azfar RS, Gelfand JM.: Psoriasis and Metabolic Disease: Epidemiology and Pathophysiology. Curr Opin Rheumatol 20: 416-422, 2008 Notes: PMID: 18525354.
• Wine LL, Azfar RS, Yan AC: A Four-Month-Old Baby with Diaper Dermatitis. Pediatr Ann 37(4): 208-210, 2008.
• Azfar RS, Cohn J: Trimethoprim-Sulfamethoxazole Induced Sweet’s Syndrome. Arch Dermatol 145(2): 215-216, 2009.
• Azfar RS, Neimann AL, Shin DB, Troxel AB and Gelfand JM: The Risk of Cardiovascular Mortality in Patients with Severe Psoriasis.J Investig Dermatol 129: S63, 2009.
• Azfar RS, Ogunleye T, Treat J: Annular Blisters on the Arm: Bullous Tinea Corporis. Arch Dermatol 145(4): 497, 2009.
• Gelfand JM, Azfar RS: Psoriasis and Cardiovascular Risk: Strength in Numbers. J Investig Dermatol 130: 919-922, 2009.
• Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB: The Risk of Stroke in Patients with Psoriasis. J Invest Dermatol 129(10): 2411-2418, 2009.
• Kennedy CE, Azfar RS, Honig PJ: Lyme Disease as a Cause of Acropapular Dermatitis of Childhood. Pediatric Dermatol 26(5): 635-636, 2009.
• Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB and Gelfand JM: Patients with Severe Psoriasis are at Increased Risk of Cardiovascular Mortality: Cohort Study Using the General Practice Research Database. European Heart J 31: 1000-1006, 2009.
• Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM.:Cause-Specific Mortality in Severe Psoriasis: A Cohort Study Using the General Practice Research Database. J Investig Dermatol 130: S63, 2010.
• Azfar RS, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker W, Gelfand JM, Kovarik CK: HIV Positive Patients in Botswana Find Mobile Teledermatology an Acceptable Method for Receiving Dermatologic Care. J Investig Dermatol 130: S65, 2010.
• Azfar RS, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker W, Gelfand JM, Kovarik CL: HIV Positive Patients in Botswana State That Mobile Teledermatology is an Acceptable Method for Receiving Dermatology Care. J Telemed Telecare 17: 338-340, 2011.
• Azfar RS, Seminara NM, Shin DB, Troxel AB, Margolis DM, Gelfand JM. Increased Risk of Diabetes Mellitus and Likelihood of Receiving Diabetes Mellitus Treatment in Patients With Psoriasis. Arch Dermatol148(9):995-1000, 2012.
• Azfar RS, Lee RA, Castelo-Soccio L, Greenberg MS, Bilker W, Gelfand JM, Kovarik CL: Reliability and Validity of Mobile Teledermatology in HIV Positive Patients in Botswana: a Pilot Study. JAMA Dermatol (in press)
• Azfar RS, Neimann AL, Shin DB, Troxel AB, Gelfand JM: Risk of Cardiovascular Mortality in Patients with Severe Psoriasis: a Population-Based Study Using the General Practice Research Database. Society for Investigative Dermatology Meeting, Montreal, Canada 2009.
• Azfar RS, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker W, Gelfand JM, Kovarik CK.: HIV Positive Patients in Botswana Find Mobile Teledermatology an Acceptable Method for Receiving Dermatologic Care. Penn Center for AIDS Research Annual Research Retreat, Philadelphia, PA 2009.
• Kovarik CL, Azfar RS, Cavric G, Szep Z, Ratcliffe S, Gormley RH, Weinber J, Steiner A, Lee R, Castelo-Cossio L, Quinley KE, Ramogola-Masire D: The Use of Mobile Telemedicine for Remote Diagnosis in HIV-Infected Patients in Botswana. AIDS Impact 9th International Conference, Gaborone, Botswana 2009.
• Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM: Patients with Severe Psoriasis and No History of Cardiovascular Disease Are at Increased Risk of Cardiovascular Mortality. Abstract 1640, American Heart Association Scientific Sessions Meeting, Orlando, FL 2009.
• Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM: Patients with Severe Psoriasis and No History of Cardioavscular Disease Are at Increased Risk of Cardiovascular Mortality. Abstract 1640. Circulation 120: S536-b, 2009.
• Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM.: Cause-specific mortality in severe psoriasis: A cohort study using the general practice research database. Society for Investigational Dermatology Meeting, Atlanta, GA 2010.
• Azfar RS, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker W, Gelfand JM, Kovarik CK.: HIV Positive Patients in Botswana Find Mobile Teledermatology an Acceptable Method for Receiving Dermatologic Care. Society for Investigative Dermatology Meeting, Atlanta, GA 2010.
• Azfar RS, Van Voorhees A: Ultraviolet and Laser Therapy. Milestones in Drug Therapy. Treatment of Psoriasis. Wineberg J (eds.). Basel, Switzerland: Birkhauser-Verlag AG, Page: 71-102, 2008.
• Reliability and Validity of Mobile Teledermatology in Human Immunodeficiency Virus–Positive Patients in Botswana: A Pilot Study Journal of the American Medical Society, Dermatology Edition July 2014.

Dermatology and Laser Group Testimonials